Advertisement
A closer look at the updated guidance
For the first time in nearly two decades, an update in the management of acute ischemic priapism, the most common type of penile priapism, has been endorsed by the American Urological Association (AUA). This is the first joint guideline from the AUA and the Sexual Medicine Society of North America (SMSNA) on the topic.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Acute ischemic priapism is characterized by a persistent and often painful erection lasting more than four hours and not associated with sexual stimulation. The condition, also known as low-flow priapism, is a medical emergency. Lack of timely or proper intervention can lead to corporal scarring, which can result in longer-term erectile dysfunction and loss of penile size.
“Early intervention is key, as is counseling patients on the long-term risks of sexual function,” says Petar Bajic, MD, Assistant Professor of Urology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and a urologist in the Center for Men’s Health in the Glickman Urological and Kidney Institute.
The medical intervention for patients with priapism for more than four hours includes aspiration with or without irrigation, combined with an intracavernosal injection of a sympathomimetic drug. But when patients are refractory, surgical intervention is warranted. The updated guidelines focus largely on changes to surgical management of men who fail phenylephrine injection with or without corporal aspiration.
Dr. Bajic explains: “For men who fail aspiration, these cases have been historically managed with shunting, which has negative implications for erectile function. In the prior guideline, management would typically start with a distal shunt, and then move more proximally. However, the newer guideline move away from proximal venous shunts, like the Grayhack procedure, and present the option of tunneling at the time of distal shunting, or in the setting of a failed distal shunt without tunneling. This tunneling allows for improved effectiveness without the morbidity of proximal shunt procedures for which the guidelines state there is inadequate evidence to identify a benefit,” he says.
Advertisement
“This guideline is also the first to state that penile prosthesis implantation can be considered for any patient with an erection for more than 36 hours, or for those refractory to shunting with or without tunneling, after discussion with the physician about the relative risks and benefits of immediate versus delayed placement,” says Dr. Bajic.
In addition to changes in surgical management, the updated guidelines also focus on the importance of counseling patients on the risks for erectile function and setting realistic expectations for patients with prolonged priapism that their erectile function is unlikely to return.
At the center of this updated guidance is an increased focus on quality of life and longer-term outcomes. “By adding a focus on preserving long-term sexual function to the management of priapism, the guidelines attempt to offer patients options that may lead to a more satisfactory end result,” notes Dr. Bajic.
He is hopeful that one day surgical techniques can correct priapism without compromising long-term sexual function and without the need for a penile prosthesis.
“Newer techniques, including a procedure called penoscrotal decompression, have been described, but more research is needed to compare outcomes to those of the current guidelines,” he concludes.
Advertisement
Advertisement
What updated techniques, counseling and a changing workforce could mean
Applications, outcomes and untapped potential
Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes
Early, individualized diagnosis and comprehensive management key to preserving fertility
Up to 3 days faster than waiting for urine culture results
Review the advantages and disadvantages of newer interventions
Pioneering and refining the approach in pyeloplasty, nephrectomy and more
Unlike earlier pills, new drugs do not cause liver toxicity